文献速递眼底病与葡萄膜炎

两大陆人群研究中的近视性黄斑萎缩

Myopic Macular Atrophy in the Two-Continent Population-Based Study.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2024-01-01

在乌拉尔眼科与医学研究、北京眼科研究和乌拉尔高龄研究中,基于人群的横断面分析显示,所有可评估的近视性黄斑萎缩(MMD 4期)眼均存在中心凹Bruch膜缺陷(BMD)伴视网膜下增殖(SRP),而斑片状萎缩(MMD 3期)则分为有BMD和SRP与无BMD和SRP两类;无论MMD分期如何,BMD与SRP的患病率均高度显著相关。

要点

  • MMD 4期眼在三个队列中均普遍存在中心凹BMD和SRP。
  • MMD 3期眼中BMD和SRP的患病率在三队列分别为44%和33%、17%和11%、71%和33%。
  • BMD与SRP的患病率在所有MMD分期中均高度显著相关。

核心结论

  • 所有可评估的近视性黄斑萎缩眼均显示中心凹BMD伴SRP,斑片状萎缩可分为有BMD和SRP与无BMD和SRP两类;独立于MMD分期,BMD与SRP的患病率高度显著相关。

研究设计与样本

  • 基于人群的横断面研究,纳入乌拉尔眼科与医学研究(UEMS,年龄40岁及以上)、北京眼科研究(BES)和乌拉尔高龄研究(UVOS,年龄85岁及以上)三个不同种族队列。
  • UEMS共5794名参与者,UVOS共930名参与者,BES共3468名参与者;主要结局指标为BMD和SRP的患病率。

主要发现

  • UEMS中19眼为MMD 4期,17眼(89%)有中心凹BMD,2眼无法完全探查;全部19眼均显示局限性SRP;MMD 3期21眼中BMD为9/21(44%),SRP为7/21(33%)。
  • UVOS中17眼为MMD 4期,16眼(94%)有中心凹BMD和SRP,1眼无法评估;MMD 3期18眼中BMD为3/18(17%),SRP为2/18(11%)。
  • BES中8眼为MMD 4期,全部眼均有中心凹BMD和SRP;MMD 3期14眼中BMD为10/14(71%),SRP为7/21(33%),原文此处SRP分母写作21,按上下文应为14。

关键数值与推荐

  • MMD 4期:UEMS中17/19眼(89%)有中心凹BMD,UVOS中16/17眼(94%)有中心凹BMD和SRP,BES中8/8眼有中心凹BMD和SRP。
  • MMD 3期:UEMS中BMD 9/21(44%)、SRP 7/21(33%);UVOS中BMD 3/18(17%)、SRP 2/18(11%);BES中BMD 10/14(71%)、SRP 7/21(33%)(原文此处SRP分母为21,按上下文应为14)。
  • 独立于MMD分期,BMD与SRP的患病率高度显著相关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • UEMS中2眼无法完全探查,UVOS中1眼无法评估。
  • BES中MMD 3期SRP分母原文写作21,按上下文应为14,原文此处表述有矛盾。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To examine the prevalence of Bruch's membrane defects (BMDs) and subretinal proliferations (SRPs) in highly myopic eyes with myopic macular atrophy (myopic macular degeneration [MMD] stage 4) and myopic patchy atrophies (MMD stage 3) in three ethnically different cohorts recruited in a population-based manner. METHODS: The Ural Eye and Medical Study (UEMS) and Beijing Eye Study (BES) included individuals aged 40+ years, and the Ural Very Old Study (UVOS) examined individuals aged 85+ years. Main outcome measures were the prevalence of BMDs and SRPs. RESULTS: Among 5794 UEMS participants, 19 eyes had MMD stage 4, with 17 (89%) eyes showing a foveal BMD; two eyes could not fully be explored. All 19 eyes showed localized SRPs. Among 21 eyes with MMD stage 3, BMD and SRP prevalence was 9 of 21 (44%) and 7 of 21 (33%), respectively. Among 930 UVOS participants, 17 eyes had MMD stage 4, with 16 (94%) eyes showing foveal BMDs and SRPs; one eye could not be assessed. Among 18 eyes with MMD stage 3, BMD and SRP prevalence was 3 of 18 (17%) and 2 of 18 (11%), respectively. Among 3468 BES participants, 8 eyes had MMD stage 4, with all eyes showing foveal BMDs and SRPs. Among 14 eyes with MMD stage 3, BMD and SRP prevalence was 10 of 14 (71%) and 7 of 21 (33%), respectively. CONCLUSIONS: All eyes with assessable myopic macular atrophy showed foveal BMDs associated with SRPs, while patchy atrophies could be differentiated into those with BMDs and SRPs and those without BMDs and without SRPs. Independent of the MMD stage, the prevalences of BMDs and SRPs were highly significantly associated with each other.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Jonas JB, Bikbov MM, Kazakbaeva GM, et al. Myopic Macular Atrophy in the Two-Continent Population-Based Study. Invest Ophthalmol Vis Sci. 2024. PMID: 39042402. doi:10.1167/iovs.65.8.38

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。